Medical disclaimer. This page is for tracking and education only. It is not medical advice and it never recommends doses. Talk with your prescriber or care team before you change, lower, or stop any medication. Ozempic, Wegovy, Mounjaro, and Zepbound are named only to describe what readers search for.
This taper timeline is a place to record the dose steps you and your clinician set. It does not create a glp1 taper plan, and it does not tell you when to stop, change, or restart any medicine.
Some people want a simple record when they are tapering, maintaining, or looking back after a GLP-1 medicine. The app is built to help you keep that history organized, not to make decisions for you.
A record you enter, not a plan the app makes
You type in the dose steps, dates, and notes that were discussed with your prescriber or care team. The app keeps those entries together in a timeline so you can review them later.
If you are reading about tapering first, you may also want this guide on taper schedules. It is for education only and should be read alongside advice from your clinician.
What you can write down
- The dose step you were given or discussed
- The date each step was recorded
- Notes from your visit, such as appetite changes or questions for next time
- Any observations you want to bring to your clinician
The app can also help you keep an eye on other tracking features across the app features, so your notes stay in one place.
What the app never does
The app never calculates, validates, or suggests doses. It does not give a taper schedule for Wegovy or Zepbound, and it does not replace your prescriber’s instructions.
The FDA prescribing information for Wegovy and Zepbound does not give a dose taper schedule for stopping the medicine, so the app does not suggest one. Stopping or changing a dose is a decision for the prescriber. In research on tirzepatide, adults who switched to placebo after 36 weeks gained weight on average, while those who continued lost more weight over the later study period. That result does not tell you what to do with your own medication.
For more on how we handle medication-related content, see the medical disclaimer.
Bring it to your visit
A clear timeline can make it easier to answer questions at a follow-up visit. You can show your clinician what was recorded, what changed, and what you noticed over time.
If eating feels hard while you are tracking appetite, weight, or food patterns, talk with a clinician. The app is for organization and education only, not treatment or diagnosis.
Join the iOS waitlist from Get the app.
Key facts
- In SURMOUNT-4 (JAMA 2024), from week 36 to week 88 people switched to placebo gained 14.0% of body weight, while those who continued tirzepatide lost a further 5.5%. Source
- FDA labels for Wegovy and Zepbound do not provide a taper schedule for stopping. Source
Sources
Last updated: